Atlas Trials

Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

Clinical trial NCT00820742 · WITHDRAWN

Trial details

NCT number
NCT00820742
Sponsor
Pfizer
Status
WITHDRAWN
Study type
OBSERVATIONAL
Neovascular Age-related Macular Degeneration
Start date
2008-02-01
Primary completion
2009-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.